0001273636-21-000009.txt : 20210617 0001273636-21-000009.hdr.sgml : 20210617 20210617185416 ACCESSION NUMBER: 0001273636-21-000009 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210609 FILED AS OF DATE: 20210617 DATE AS OF CHANGE: 20210617 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Reynolds Gerald Anthony CENTRAL INDEX KEY: 0001867439 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36370 FILM NUMBER: 211026419 MAIL ADDRESS: STREET 1: C/O APPLIED GENETIC TECHNOLOGIES CORP. STREET 2: 14193 NW 119TH TERRACE, SUITE 10 CITY: ALACHUA STATE: FL ZIP: 32615 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: APPLIED GENETIC TECHNOLOGIES CORP CENTRAL INDEX KEY: 0001273636 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 593553710 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 14193 NW 119TH TERRACE STREET 2: SUITE #10 CITY: ALACHUA STATE: FL ZIP: 32615 BUSINESS PHONE: 386-462-2204 MAIL ADDRESS: STREET 1: 14193 NW 119TH TERRACE STREET 2: SUITE #10 CITY: ALACHUA STATE: FL ZIP: 32615 3 1 edgar.xml PRIMARY DOCUMENT X0206 3 2021-06-09 0 0001273636 APPLIED GENETIC TECHNOLOGIES CORP AGTC 0001867439 Reynolds Gerald Anthony C/O APPLIED GENETIC TECHNOLOGIES CORP. 14193 NW 119TH TERRACE, SUITE #10 ALACHUA FL 32615 0 1 0 0 Chief Accounting Officer Common Stock 25000 D Stock Option (right to buy) 3.28 2030-03-30 Common Stock 50000 D Stock Option (right to buy) 5.5 2030-08-05 Common Stock 30000 D Represents a grant of restricted stock units ("RSUs") under the Applied Genetic Technologies Corporation ("AGTC") 2013 Equity and Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of AGTC common stock. The RSUs vest in two equal annual installments, with 50% vesting on May 26, 2022 and the remaining 50% vesting on May 26, 2023, subject to the Reporting Person's continued employment with or performance of services for the Company as of each vesting date. The option was granted on March 30, 2020. The option became exercisable for 25% of the underlying shares on the first anniversary of the grant date, and thereafter became and continues to become, as applicable, exercisable for the remaining underlying shares in equal monthly installments over three years, resulting in the option being exercisable for 100% of the underlying shares on the fourth anniversary of the grant date. The option was granted on August 5, 2020. The option became and continues to become exercisable in equal monthly installments over four years from the date of grant. Exhibit 24 Power of Attorney filed herewith. /s/ Stacie Aarestad, Attorney-in-fact 2021-06-17 EX-24 2 attachment_2.htm GERALD ANTHONY REYNOLDS POWER OF ATTORNEY

POWER OF ATTORNEY



KNOW ALL BY THESE PRESENTS, that the undersigned hereby authorizes Hemmie Chang Stacie Aarestad and Ryan Rourke Reed, each of Foley Hoag LLP and each acting singly, to execute for and on behalf of the undersigned, in the undersigned's capacity as an officer of Applied Genetic Technologies Corporation (the "Company"), a Form ID, Forms 3, 4 and 5, and any amendments thereto, and cause such form(s) to be filed with the United States Securities and Exchange Commission pursuant to Section 16(a) of the Securities Act of 1934, relating to the undersigned's beneficial ownership of securities in the Company. The undersigned hereby grants to the attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do personally present, with full power of substitution, resubstitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney's-in-fact substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorney-in-fact, in serving in such capacity at the request of the undersigned, is not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of, and transactions in, securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorney-in-fact.



IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 17th day of May, 2021.



/s/ Gerald Anthony Reynolds

Gerald Anthony Reynolds